NEUP Neuphoria Therapeutics Inc. - Common Stock
$4,81
Prix · Mai 20, 2026
Données fondamentales au Mai 15, 2026
Fourchette 52 semaines
$4–$21
7% of range
Note des analystes
BUY
9 analysts
Objectif de cours
$7
+46% upside
P/E (TTM)
-30.9
ROE
-2.3%
Marge nette
-2.4%
NEUP Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$4.80
Capitalisation Boursière
$14M
P/E (TTM)
-30.9
BPA (TTM)
$-0.23
Revenus (TTM)
$16M
Rendement div.
—
ROE
-2.3%
Dette/Capitaux propres
—
Fourchette 52 semaines
$4 – $21
NEUP Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$16M
2025-06-30
→
2025-06-30
BPA
$-0.23
2023-06-30
→
2025-06-30
Flux de trésorerie libre
—
Marges
-2.4%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
NEUP
Médiane des pairs
P/E (TTM)
-30.9
0.1
P/S (TTM)
0.9
64.9
P/B
0.7
1.7
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
NEUP
Médiane des pairs
Operating Margin (Marge d'exploitation)
-7.2%
—
Net Profit Margin (Marge nette)
-2.4%
-127.5%
ROA
-1.3%
-70.0%
ROE
-2.3%
-143.6%
ROIC
-2.6%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
NEUP
Médiane des pairs
Current Ratio (Ratio de liquidité)
3.6
3.3
Quick Ratio (Ratio de liquidité réduite)
3.4
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
NEUP
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
NEUP
Médiane des pairs
NEUP Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
9 analystes
- Achat fort 2 22,2%
- Achat 5 55,6%
- Conserver 2 22,2%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
1 analystes · 2026-05-17
Bas
$7.00
Haut
$7.00
Objectif médian
$7.00
+45,7%
Objectif moyen
$7.00
+45,7%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-1.3%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 septembre 2026 | $-0.09 | $-0.99 | — |
| 31 mars 2026 | $-0.09 | $-0.99 | 0.90% |
| 31 décembre 2025 | $-0.77 | $-1.49 | 0.72% |
| 30 septembre 2025 | $-4.41 | $-1.35 | -3.1% |
| 30 juin 2025 | $-5.79 | $-2.12 | -3.7% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| NEUP | $14M | -30.9 | — | -2.4% | -2.3% | — |
| PPCB | $48M | -0.3 | — | — | -1209.0% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 |
|---|---|---|
| Revenue | $16M | |
| R&D Expense | $9M | |
| SG&A Expense | $8M | |
| Operating Expenses | $17M | |
| Operating Income | $-1M | |
| Interest Income | $166.5K | |
| Other Non-op | $291.1K | |
| Pretax Income | $-838.0K | |
| Income Tax | $-468.4K | |
| Net Income | $-400.0K | |
| EPS (Basic) | $-0.23 | |
| EPS (Diluted) | $-0.23 | |
| Shares (Basic) | 1,622,924 | |
| Shares (Diluted) | 1,622,924 | |
| EBITDA | $-1M |
Bilan 19
| Métrique | Tendance | 2025 |
|---|---|---|
| Cash & Equivalents | $14M | |
| Receivables | $11.9K | |
| Prepaid Expense | $740.2K | |
| Current Assets | $15M | |
| PP&E (Net) | $2.8K | |
| Goodwill | $9M | |
| Intangibles | $5M | |
| Total Assets | $29M | |
| Accounts Payable | $1M | |
| Current Liabilities | $4M | |
| Deferred Tax | $495.1K | |
| Total Liabilities | $10M | |
| Common Stock | $19 | |
| Paid-in Capital | $200M | |
| Retained Earnings | $-178M | |
| AOCI | $-3M | |
| Stockholders' Equity | $19M | |
| Liabilities + Equity | $29M | |
| Shares Outstanding | 1,978,460 |
Flux de trésorerie 8
| Métrique | Tendance | 2025 |
|---|---|---|
| D&A | $662.9K | |
| Stock-based Comp | $163.8K | |
| Deferred Tax | $-468.4K | |
| Operating Cash Flow | $77.2K | |
| Stock Issued | $2M | |
| Net Stock Activity | $2M | |
| Financing Cash Flow | $2M | |
| Net Change in Cash | $2M |
Rentabilité 7
| Métrique | Tendance | 2025 |
|---|---|---|
| Operating Margin | -7.2% | |
| Net Margin | -2.4% | |
| Pretax Margin | -5.3% | |
| EBITDA Margin | -7.2% | |
| ROA | -1.3% | |
| ROE | -2.3% | |
| ROIC | -2.6% |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 |
|---|---|---|
| Current Ratio | 3.6 | |
| Quick Ratio | 3.4 |
Efficacité 2
| Métrique | Tendance | 2025 |
|---|---|---|
| Asset Turnover | 0.6 | |
| Receivables Turnover | 225.4 |
Valorisation (TTM) 9
| Métrique | Tendance | 2025 |
|---|---|---|
| Revenue TTM | $16M | |
| Net Income TTM | $-400.0K | |
| Market Cap | $14M | |
| P/E | -30.9 | |
| P/S | 0.9 | |
| P/B | 0.7 | |
| P / Tangible Book | 2.5 | |
| P / Cash Flow | 181.9 | |
| Earnings Yield | -3.2% |
Compte de résultat 15
| Métrique | Tendance | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $-13.3K | $15M | $662.7K | |
| R&D Expense | · | $697.7K | $4M | $4M | $2M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $1M | $3M | |
| Operating Expenses | $1M | $4M | $6M | $6M | $3M | $4M | |
| Operating Income | $-1M | $-4M | $-6M | $-6M | $12M | $-4M | |
| Interest Income | $186.2K | $167.3K | $142.0K | $87.0K | $12.7K | $30.6K | |
| Other Non-op | $671.8K | $6M | $-4M | $-3M | $-796.2K | $2M | |
| Pretax Income | $-539.9K | $2M | $-10M | $-9M | $11M | $-2M | |
| Income Tax | $-34.8K | $-34.8K | $-34.8K | $-266.6K | $-81.2K | $11.6K | |
| Net Income | $-505.1K | $2M | $-10M | $-9M | $11M | $-2M | |
| EPS (Basic) | $-0.09 | $0.41 | $-4.41 | $-4.93 | $6.55 | $-1.23 | |
| EPS (Diluted) | $-0.09 | $-0.77 | $-4.41 | $-4.37 | $6.55 | $-1.79 | |
| Shares (Basic) | 5,411,244 | 4,536,235 | 2,246,066 | -2,971,458 | 1,719,073 | 1,575,244 | |
| Shares (Diluted) | 5,411,244 | 4,536,235 | 2,246,066 | -2,971,458 | 1,719,073 | 1,575,244 | |
| EBITDA | $-1M | $-4M | $-6M | · | $12M | $-4M |
Bilan 21
| Métrique | Tendance | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $22M | $14M | $14M | $17M | $4M | |
| Receivables | $2M | $1M | $1.8K | $11.9K | $24.6K | $35.6K | |
| Prepaid Expense | $611.9K | $27.0K | $222.3K | $740.2K | $20.9K | $18.5K | |
| Current Assets | $22M | $23M | $14M | $15M | $17M | $4M | |
| PP&E (Net) | · | · | $2.6K | $2.8K | $1.6K | $1.7K | |
| Goodwill | $9M | $9M | $9M | $9M | $8M | $8M | |
| Intangibles | $4M | $4M | $5M | $5M | $5M | $5M | |
| Total Assets | $35M | $37M | $27M | $29M | $31M | $18M | |
| Accounts Payable | $627.2K | $520.7K | $1M | $1M | $745.3K | $2M | |
| Current Liabilities | $2M | $3M | $5M | $4M | $2M | $2M | |
| Capital Leases | · | · | · | · | $19.3K | $49.8K | |
| Deferred Tax | $390.7K | $425.5K | $460.3K | $495.1K | $761.7K | $842.9K | |
| Other Non-current Liabilities | · | · | · | · | $3.6K | $3.4K | |
| Total Liabilities | $5M | $7M | $15M | $10M | $5M | $4M | |
| Common Stock | $54 | $54 | $23 | $19 | $19 | $16 | |
| Paid-in Capital | $218M | $218M | $204M | $200M | $199M | $198M | |
| Retained Earnings | $-187M | $-186M | $-188M | $-178M | $-169M | $-181M | |
| AOCI | $-2M | $-2M | $-3M | $-3M | $-4M | $-4M | |
| Stockholders' Equity | $29M | $30M | $13M | $19M | $26M | $14M | |
| Liabilities + Equity | $35M | $37M | $27M | $29M | $31M | $18M | |
| Shares Outstanding | 5,377,329 | 5,377,329 | 2,357,613 | 1,978,460 | 1,853,966 | 1,628,659 |
Flux de trésorerie 8
| Métrique | Tendance | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| D&A | $165.7K | $165.8K | $165.8K | $165.6K | $165.4K | $166.1K | |
| Stock-based Comp | $70.3K | $93.7K | $111.3K | $98.3K | $19.7K | $19.1K | |
| Restructuring | $42.4K | $1M | · | · | · | · | |
| Operating Cash Flow | $-3M | $-6M | $-4M | $-4M | $11M | $-3M | |
| Stock Issued | $0 | $15M | $3M | $704.7K | $823.6K | $0 | |
| Net Stock Activity | · | · | $3M | · | · | · | |
| Financing Cash Flow | $0 | $15M | $3M | $704.7K | $1M | $-111.6K | |
| Net Change in Cash | $-3M | $9M | $-560.5K | $-3M | $13M | $-4M |
Rentabilité 7
| Métrique | Tendance | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | 79.8% | -558.8% | |
| Net Margin | · | · | · | · | 75.1% | -293.2% | |
| Pretax Margin | · | · | · | · | 74.5% | -291.5% | |
| EBITDA Margin | · | · | · | · | 79.8% | -558.8% | |
| ROA | -1.5% | 6.8% | -39.4% | · | 73.3% | -21.4% | |
| ROE | -1.8% | 8.6% | -67.0% | · | 86.6% | -28.3% | |
| ROIC | -3.9% | -13.9% | -45.0% | · | 46.4% | -27.1% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 14.3 | 9.0 | 2.7 | · | 11.0 | 2.1 | |
| Quick Ratio | 13.9 | 9.0 | 2.7 | · | 11.0 | 2.1 |
Efficacité 2
| Métrique | Tendance | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 1.0 | 0.1 | |
| Receivables Turnover | · | · | · | · | 1219.9 | 37.3 |
Valorisation (TTM) 7
| Métrique | Tendance | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $3M | $1M | $-1M | · | $6M | $-10M | |
| Market Cap | $22M | $21M | $28M | · | $11M | $6M | |
| P/E | 3.2 | -9.2 | -43.7 | · | 4.4 | -0.3 | |
| P/B | 0.7 | 0.7 | 2.2 | · | 0.4 | 0.4 | |
| P / Tangible Book | 1.3 | 1.3 | · | · | 0.8 | 27.3 | |
| P / Cash Flow | · | · | -7.3 | · | · | · | |
| Earnings Yield | 31.4% | -10.8% | -2.3% | · | 22.7% | -307.6% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-06-30 | 2024-06-30 | 2023-06-30 | |
|---|---|---|---|
| Revenu | $16M | — | — |
| Marge d'exploitation % | -7.2% | — | — |
| Résultat net | $-400.0K | $-15M | $-21M |
| BPA dilué | $-0.23 | $-18.62 | $-0.02 |
Bilan
| 2025-06-30 | 2024-06-30 | 2023-06-30 | |
|---|---|---|---|
| Ratio de liquidité | 3.6 | 3.4 | — |
| Ratio de liquidité réduite | 3.4 | 3.3 | — |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.